David S Siegel MD PhD

PubMed

• Combined Immune Checkpoint Inhibitors and Radiation Therapy in Patients with Multiple Myeloma and Extramedullary Medullary Disease: A Real-World Retrospective Analysis.
  Lili Zhang, Ayrton Bangolo, Behzad Amoozgar, Sarvarinder Gill, Jiahe Zhao
  Cancers. 2026-06-19
• Salvage Therapy in Multiple Myeloma With Prior T-Cell Engager Exposure: Talquetamab, Elranatamab or Teclistamab in Combination With Pomalidomide.
  James Di Palma-Grisi, David Vesole, David Siegel, Noa Biran, Pooja Phull
  European Journal of Haematology. 2026-06-01
• Consolidation Therapy with Checkpoint Inhibitors After Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Multiple Myeloma and Lymphoma.
  Lindsay Fogel, Patrick C Roney, Jaeil Ahn, Joshua Zenreich, Adolfo Aleman
  Transplantation and Cellular Therapy. 2026-05-14

Journal Articles

• Carfilzomib vs Bortezomib in Patients with Multiple Myeloma and Renal Failure: A Subgroup Analysis of ENDEAVOR  
  Ruben Niesvizky, David Siegel, Ralph Boccia, Blood
• Updated survival analyses after prolonged follow-up of the phase 2, multicenter CReST study of bortezomib in relapsed or refractory multiple myeloma  
  Jagannath S, Barlogie B, Berenson JR, Siegel DS, Irwin D, Richardson PG,Niesvizky R, Alexanian R, Limentani SA, Alsina M, esseltine DL, Anderson KC, Br J Haematol, 1/1/2014
• Phase I Trial of Anti-CS1 Monoclonal Antibody elotuzumab in Combination With Bortezomib in the Treatment of Relapsed/Refractory Multiple Myeloma  
  Jakubowiak AJ, Benson DM, Bensinger W, Siegel DS, Zimmerman TM, Mohrbacher A, Richardson PG, Afar De, Singhal AK, Anderson KC, J Clin Oncol, 1/30/2012

Books/Book Chapters

• Advances in Internal Medicine 
  Chapter: Advances in the treatment of multiple myeloma. 
  Barlogie B, Jagannath S, Tricot G, Desikan KR, Fassas A and Siegel DMosby-Year Book1998
• C-Myc in B-Cell Neoplasia. 14th Workshop on Mechanisms in B-Cell Neoplasia 
  Chapter: Myc/Max family of transcription factors and bcl-2 are involved in drug-induced apoptosis of myeloma cells. 
  Siegel DS, Terry JA, Koury J, Barlogie B, epstein J and Feinman REditors: Potter M and Melchers F.Springer-Verlag1997
• The Interferon System 
  Chapter: Interferon-gamma induction in peripheral blood leukocytes by interleukin-2: Role of monocytes, interleukin-1 and interferon-gamma. 
  Vilcek J, Henriksen-DeStefano D, Siegel D and Le JEditors: Dianziani F and Rossi GB.Raven Press1984

Lectures

• CAR T-Cell Therapy in Lymphoma, Myeloma, and Leukemia _ Clinical Updates and Innovations 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Efficacy and Safety of Carfilzomib and Dexamethasone in Lenalidomide Exposed and Refractory Multiple Myeloma Patients: Combined Analysis of Carfilzomib Trials 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (Ipi) and Nivolumab (Nivo) As Consolidation Following Autologous Stem Cell Transplantation ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018